psalexa

Wound Care Biologics Market Research Report: By Product (Skin Substitutes, Growth Factors, Collagen-Based, Cell-Based, Enzyme-Based), Durability (Permanent, Temporary), Formulation (Topical), Application (Chronic, Acute), End-User (Hospitals & Specialty Clinics, ASCs, Home Care), Geographical Outlook (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, Australia, Mexico, Brazil, Saudi Arabia, South Africa, Israel) – Industry Size and Share Analysis and Growth Forecast to 2024

  • Published: December 2019
  • Report Code: LS11612
  • Available Format: PDF
  • Pages: 379

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Durability

1.3.3 Market Segmentation by Formulation

1.3.4 Market Segmentation by Application

1.3.5 Market Segmentation by End User

1.3.6 Market Segmentation by Geography

1.3.7 Analysis Period

1.3.8 Market Data Reporting Unit

1.3.8.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Skin substitutes

4.1.1.1.1 Human donor tissue-derived

4.1.1.1.2 Acellular animal-derived

4.1.1.1.3 Biosynthetic

4.1.1.2 Growth factors

4.1.1.2.1 PDGF

4.1.1.2.2 FGF

4.1.1.2.3 EGF

4.1.1.2.4 Transforming growth factor-beta (TGF-β)

4.1.1.2.5 Insulin-like growth factors (IGF)

4.1.1.2.6 Others

4.1.1.3 Collagen-based

4.1.1.4 Cell-based

4.1.1.4.1 Viable

4.1.1.4.2 Non-viable

4.1.1.5 Enzyme-based

4.1.1.6 Others

4.1.2 By Durability

4.1.2.1 Permanent

4.1.2.2 Temporary

4.1.3 By Formulation

4.1.3.1 Topical

4.1.3.2 Others

4.1.4 By Application

4.1.4.1 Chronic

4.1.4.1.1 DFU

4.1.4.1.2 Pressure ulcers

4.1.4.1.3 VLU

4.1.4.2 Acute

4.1.4.2.1 Surgical, traumatic, and burn injuries

4.1.4.2.2 Others

4.1.5 By End User

4.1.5.1 Hospitals & specialty clinics

4.1.5.1.1 Inpatient

4.1.5.1.2 Outpatient

4.1.5.2 ASCs

4.1.5.3 Home care

4.2 Market Dynamics

4.2.1 Trends

4.2.2 Drivers

4.2.3 Restraints

4.2.4 Opportunities

4.3 Porter’s Five Forces Analysis

4.4 Regulatory Overview

4.5 List of Wound Care Societies

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 Skin Substitutes Market, by Type

5.1.2 Growth Factors Market, by Type

5.1.3 Cell-Based Wound Care Biologics Market, by Type

5.2 By Durability

5.3 By Formulation

5.4 By Application

5.4.1 Wound Care Biologics Market for Acute Wounds, by Type

5.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

5.5 By End User

5.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

5.6 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Product

6.1.1 Skin Substitutes Market, by Type

6.1.2 Growth Factors Market, by Type

6.1.3 Cell-Based Wound Care Biologics Market, by Type

6.2 By Durability

6.3 By Formulation

6.4 By Application

6.4.1 Wound Care Biologics Market for Acute Wounds, by Type

6.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

6.5 By End User

6.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

6.6 By Country

6.6.1 U.S. Market Size and Forecast

6.6.1.1 By product

6.6.1.1.1 Skin substitutes market, by type

6.6.1.1.2 Growth factors market, by type

6.6.1.1.3 Cell-based wound care biologics market, by Type

6.6.1.2 By durability

6.6.1.3 By formulation

6.6.1.4 By application

6.6.1.4.1 Wound care biologics market for acute wounds, by type

6.6.1.4.2 Wound care biologics market for chronic wounds, by type

6.6.1.5 By end user

6.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type

6.6.2 Canada Market Size and Forecast

6.6.2.1 By product

6.6.2.1.1 Skin substitutes market, by type

6.6.2.1.2 Growth factors market, by type

6.6.2.1.3 Cell-based wound care biologics market, by type

6.6.2.2 By durability

6.6.2.3 By formulation

6.6.2.4 By application

6.6.2.4.1 Wound care biologics market for acute wounds, by type

6.6.2.4.2 Wound care biologics market for chronic wounds, by type

6.6.2.5 By end user

6.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type

Chapter 7. Europe Market Size and Forecast

7.1 By Product

7.1.1 Skin Substitutes Market, by Type

7.1.2 Growth Factors Market, by Type

7.1.3 Cell-Based Wound Care Biologics Market, by Type

7.2 By Durability

7.3 By Formulation

7.4 By Application

7.4.1 Wound Care Biologics Market for Acute Wounds, by Type

7.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

7.5 By End User

7.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

7.6 By Country

7.6.1 Germany Market Size and Forecast

7.6.1.1 By product

7.6.1.1.1 Skin substitutes market, by type

7.6.1.1.2 Growth factors market, by type

7.6.1.1.3 Cell-based wound care biologics market, by type

7.6.1.2 By durability

7.6.1.3 By formulation

7.6.1.4 By application

7.6.1.4.1 Wound care biologics market for acute wounds, by type

7.6.1.4.2 Wound care biologics market for chronic wounds, by type

7.6.1.5 By end user

7.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type

7.6.2 France Market Size and Forecast

7.6.2.1 By product

7.6.2.1.1 Skin substitutes market, by type

7.6.2.1.2 Growth factors market, by type

7.6.2.1.3 Cell-based wound care biologics market, by type

7.6.2.2 By durability

7.6.2.3 By formulation

7.6.2.4 By application

7.6.2.4.1 Wound care biologics market for acute wounds, by type

7.6.2.4.2 Wound care biologics market for chronic wounds, by type

7.6.2.5 By end user

7.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type

7.6.3 U.K. Market Size and Forecast

7.6.3.1 By product

7.6.3.1.1 Skin substitutes market, by type

7.6.3.1.2 Growth factors market, by type

7.6.3.1.3 Cell-based wound care biologics market, by type

7.6.3.2 By durability

7.6.3.3 By formulation

7.6.3.4 By application

7.6.3.4.1 Wound care biologics market for acute wounds, by type

7.6.3.4.2 Wound care biologics market for chronic wounds, by type

7.6.3.5 By end user

7.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type

7.6.4 Italy Market Size and Forecast

7.6.4.1 By product

7.6.4.1.1 Skin substitutes market, by type

7.6.4.1.2 Growth factors market, by type

7.6.4.1.3 Cell-based wound care biologics market, by type

7.6.4.2 By durability

7.6.4.3 By formulation

7.6.4.4 By application

7.6.4.4.1 Wound care biologics market for acute wounds, by type

7.6.4.4.2 Wound care biologics market for chronic wounds, by type

7.6.4.5 By end user

7.6.4.5.1 Wound care biologics market in hospitals & specialty clinics, by type

7.6.5 Spain Market Size and Forecast

7.6.5.1 By product

7.6.5.1.1 Skin substitutes market, by type

7.6.5.1.2 Growth factors market, by type

7.6.5.1.3 Cell-based wound care biologics market, by type

7.6.5.2 By durability

7.6.5.3 By formulation

7.6.5.4 By application

7.6.5.4.1 Wound care biologics market for acute wounds, by type

7.6.5.4.2 Wound care biologics market for chronic wounds, by type

7.6.5.5 By end user

7.6.5.5.1 Wound care biologics market in hospitals & specialty clinics, by type

Chapter 8. APAC Market Size and Forecast

8.1 By Product

8.1.1 Skin Substitutes Market, by Type

8.1.2 Growth Factors Market, by Type

8.1.3 Cell-Based Wound Care Biologics Market, by Type

8.2 By Durability

8.3 By Formulation

8.4 By Application

8.4.1 Wound Care Biologics Market for Acute Wounds, by Type

8.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

8.5 By End User

8.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

8.6 By Country

8.6.1 China Market Size and Forecast

8.6.1.1 By product

8.6.1.1.1 Skin substitutes market, by type

8.6.1.1.2 Growth factors market, by type

8.6.1.1.3 Cell-based wound care biologics market, by type

8.6.1.2 By durability

8.6.1.3 By formulation

8.6.1.4 By application

8.6.1.4.1 Wound care biologics market for acute wounds, by type

8.6.1.4.2 Wound care biologics market for chronic wounds, by type

8.6.1.5 By end user

8.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type

8.6.2 Japan Market Size and Forecast

8.6.2.1 By product

8.6.2.1.1 Skin substitutes market, by type

8.6.2.1.2 Growth factors market, by type

8.6.2.1.3 Cell-based wound care biologics market, by type

8.6.2.2 By durability

8.6.2.3 By formulation

8.6.2.4 By application

8.6.2.4.1 Wound care biologics market for acute wounds, by type

8.6.2.4.2 Wound care biologics market for chronic wounds, by type

8.6.2.5 By end user

8.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type

8.6.3 India Market Size and Forecast

8.6.3.1 By product

8.6.3.1.1 Skin substitutes market, by type

8.6.3.1.2 Growth factors market, by type

8.6.3.1.3 Cell-based wound care biologics market, by type

8.6.3.2 By durability

8.6.3.3 By formulation

8.6.3.4 By application

8.6.3.4.1 Wound care biologics market for acute wounds, by type

8.6.3.4.2 Wound care biologics market for chronic wounds, by type

8.6.3.5 By end user

8.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type

8.6.4 Australia Market Size and Forecast

8.6.4.1 By product

8.6.4.1.1 Skin substitutes market, by type

8.6.4.1.2 Growth factors market, by type

8.6.4.1.3 Cell-based wound care biologics market, by type

8.6.4.2 By durability

8.6.4.3 By formulation

8.6.4.4 By application

8.6.4.4.1 Wound care biologics market for acute wounds, by type

8.6.4.4.2 Wound care biologics market for chronic wounds, by type

8.6.4.5 By end user

8.6.4.5.1 Wound care biologics market in hospitals & specialty clinics, by type

Chapter 9. LATAM Market Size and Forecast

9.1 By Product

9.1.1 Skin Substitutes Market, by Type

9.1.2 Growth Factors Market, by Type

9.1.3 Cell-Based Wound Care Biologics Market, by Type

9.2 By Durability

9.3 By Formulation

9.4 By Application

9.4.1 Wound Care Biologics Market for Acute Wounds, by Type

9.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

9.5 By End User

9.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

9.6 By Country

9.6.1 Mexico Market Size and Forecast

9.6.1.1 By product

9.6.1.1.1 Skin substitutes market, by type

9.6.1.1.2 Growth factors market, by type

9.6.1.1.3 Cell-based wound care biologics market, by type

9.6.1.2 By durability

9.6.1.3 By formulation

9.6.1.4 By application

9.6.1.4.1 Wound care biologics market for acute wounds, by type

9.6.1.4.2 Wound care biologics market for chronic wounds, by type

9.6.1.5 By end user

9.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type

9.6.2 Brazil Market Size and Forecast

9.6.2.1 By product

9.6.2.1.1 Skin substitutes market, by type

9.6.2.1.2 Growth factors market, by type

9.6.2.1.3 Cell-based wound care biologics market, by type

9.6.2.2 By durability

9.6.2.3 By formulation

9.6.2.4 By application

9.6.2.4.1 Wound care biologics market for acute wounds, by type

9.6.2.4.2 Wound care biologics market for chronic wounds, by type

9.6.2.5 By end user

9.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type

Chapter 10. MEA Market Size and Forecast

10.1 By Product

10.1.1 Skin Substitutes Market, by Type

10.1.2 Growth Factors Market, by Type

10.1.3 Cell-Based Wound Care Biologics Market, by Type

10.2 By Durability

10.3 By Formulation

10.4 By Application

10.4.1 Wound Care Biologics Market for Acute Wounds, by Type

10.4.2 Wound Care Biologics Market for Chronic Wounds, by Type

10.5 By End User

10.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type

10.6 By Country

10.6.1 Saudi Arabia Market Size and Forecast

10.6.1.1 By product

10.6.1.1.1 Skin substitutes market, by type

10.6.1.1.2 Growth factors market, by type

10.6.1.1.3 Cell-based wound care biologics market, by type

10.6.1.2 By durability

10.6.1.3 By formulation

10.6.1.4 By application

10.6.1.4.1 Wound care biologics market for acute wounds, by type

10.6.1.4.2 Wound care biologics market for chronic wounds, by type

10.6.1.5 By end user

10.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type

10.6.2 South Africa Market Size and Forecast

10.6.2.1 By product

10.6.2.1.1 Skin substitutes market, by type

10.6.2.1.2 Growth factors market, by type

10.6.2.1.3 Cell-based wound care biologics market, by type

10.6.2.2 By durability

10.6.2.3 By formulation

10.6.2.4 By application

10.6.2.4.1 Wound care biologics market for acute wounds, by type

10.6.2.4.2 Wound care biologics market for chronic wounds, by type

10.6.2.5 By end user

10.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type

10.6.3 Israel Market Size and Forecast

10.6.3.1 By product

10.6.3.1.1 Skin substitutes market, by type

10.6.3.1.2 Growth factors market, by type

10.6.3.1.3 Cell-based wound care biologics market, by type

10.6.3.2 By durability

10.6.3.3 By formulation

10.6.3.4 By application

10.6.3.4.1 Wound care biologics market for acute wounds, by type

10.6.3.4.2 Wound care biologics market for chronic wounds, by type

10.6.3.5 By end user

10.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type

Chapter 11. Competitive Landscape

11.1 List of Key Players

11.2 Strategic Developments of Key Players

11.2.1 Product Launches

11.2.2 Mergers and Acquisitions

Chapter 12. Company Profiles

12.1 Smith & Nephew plc

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 Mölnlycke Health Care AB

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.3 Integra LifeSciences Corporation

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.4 Wright Medical Group N.V.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.5 MiMedx Group Inc.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.6 Vericel Corporation

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.7 Anika Therapeutics Inc.

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.8 Osiris Therapeutics Inc.

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.9 Organogenesis Inc.

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.10 Kerecis Limited

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.11 Solsys Medical

12.11.1 Business Overview

12.11.2 Product and Service Offerings

12.12 Acell Inc.

12.12.1 Business Overview

12.12.2 Product and Service Offerings

12.13 Marine Polymer Technologies Inc.

12.13.1 Business Overview

12.13.2 Product and Service Offerings

12.14 Skye Biologics Inc.

12.14.1 Business Overview

12.14.2 Product and Service Offerings

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Reports

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 WOUND CARE SOCIETIES

TABLE 5 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 7 GLOBAL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 8 GLOBAL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 9 GLOBAL GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 10 GLOBAL GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 11 GLOBAL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 12 GLOBAL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 13 GLOBAL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 14 GLOBAL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 15 GLOBAL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 16 GLOBAL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 17 GLOBAL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 18 GLOBAL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 19 GLOBAL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 20 GLOBAL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 21 GLOBAL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 22 GLOBAL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 23 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 24 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 25 GLOBAL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 26 GLOBAL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 27 GLOBAL WOUND CARE BIOLOGICS MARKET, BY REGION, $M (2014–2018)

TABLE 28 GLOBAL WOUND CARE BIOLOGICS MARKET, BY REGION, $M (2019–2024)

TABLE 29 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 30 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 31 NORTH AMERICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 32 NORTH AMERICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 33 NORTH AMERICA GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 34 NORTH AMERICA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 35 NORTH AMERICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 36 NORTH AMERICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 37 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 38 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 39 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 40 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 41 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 42 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 43 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 44 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 45 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 46 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 47 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 48 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 49 WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 50 WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 51 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2018)

TABLE 52 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 53 U.S. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 54 U.S. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 55 U.S. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 56 U.S. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 57 U.S. GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 58 U.S. GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 59 U.S. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 60 U.S. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 61 U.S. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 62 U.S. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 63 U.S. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 64 U.S. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 65 U.S. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 66 U.S. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 67 U.S. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 68 U.S. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 69 U.S. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 70 U.S. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 71 U.S. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 72 U.S. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 73 U.S. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 74 U.S. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 75 CANADA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 76 CANADA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 77 CANADA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 78 CANADA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 79 CANADA GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 80 CANADA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 81 CANADA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 82 CANADA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 83 CANADA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 84 CANADA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 85 CANADA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 86 CANADA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 87 CANADA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 88 CANADA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 89 CANADA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 90 CANADA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 91 CANADA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 92 CANADA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 93 CANADA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 94 CANADA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 95 CANADA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 96 CANADA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 97 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 98 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 99 EUROPE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 100 EUROPE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 101 EUROPE GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 102 EUROPE GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 103 EUROPE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 104 EUROPE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 105 EUROPE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 106 EUROPE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 107 EUROPE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 108 EUROPE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 109 EUROPE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 110 EUROPE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 111 EUROPE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 112 EUROPE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 113 EUROPE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 114 EUROPE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 115 EUROPE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 116 EUROPE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 117 EUROPE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 118 EUROPE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 119 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2018)

TABLE 120 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 121 GERMANY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 122 GERMANY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 123 GERMANY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 124 GERMANY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 125 GERMANY GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 126 GERMANY GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 127 GERMANY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 128 GERMANY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 129 GERMANY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 130 GERMANY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 131 GERMANY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 132 GERMANY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 133 GERMANY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 134 GERMANY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 135 GERMANY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 136 GERMANY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 137 GERMANY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 138 GERMANY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 139 GERMANY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 140 GERMANY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 141 GERMANY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 142 GERMANY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 143 FRANCE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 144 FRANCE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 145 FRANCE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 146 FRANCE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 147 FRANCE GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 148 FRANCE GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 149 FRANCE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 150 FRANCE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 151 FRANCE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 152 FRANCE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 153 FRANCE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 154 FRANCE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 155 FRANCE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 156 FRANCE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 157 FRANCE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 158 FRANCE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 159 FRANCE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 160 FRANCE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 161 FRANCE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 162 FRANCE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 163 FRANCE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 164 FRANCE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 165 U.K. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 166 U.K. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 167 U.K. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 168 U.K. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 169 U.K. GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 170 U.K. GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 171 U.K. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 172 U.K. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 173 U.K. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 174 U.K. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 175 U.K. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 176 U.K. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 177 U.K. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 178 U.K. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 179 U.K. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 180 U.K. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 181 U.K. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 182 U.K. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 183 U.K. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 184 U.K. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 185 U.K. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 186 U.K. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 187 ITALY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 188 ITALY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 189 ITALY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 190 ITALY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 191 ITALY GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 192 ITALY GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 193 ITALY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 194 ITALY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 195 ITALY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 196 ITALY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 197 ITALY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 198 ITALY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 199 ITALY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 200 ITALY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 201 ITALY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 202 ITALY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 203 ITALY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 204 ITALY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 205 ITALY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 206 ITALY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 207 ITALY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 208 ITALY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 209 SPAIN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 210 SPAIN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 211 SPAIN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 212 SPAIN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 213 SPAIN GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 214 SPAIN GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 215 SPAIN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 216 SPAIN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 217 SPAIN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 218 SPAIN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 219 SPAIN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 220 SPAIN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 221 SPAIN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 222 SPAIN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 223 SPAIN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 224 SPAIN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 225 SPAIN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 226 SPAIN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 227 SPAIN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 228 SPAIN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 229 SPAIN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 230 SPAIN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 231 APAC WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 232 APAC WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 233 APAC SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 234 APAC SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 235 APAC GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 236 APAC GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 237 APAC CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 238 APAC CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 239 APAC WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 240 APAC WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 241 APAC WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 242 APAC WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 243 APAC WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 244 APAC WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 245 APAC WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 246 APAC WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 247 APAC WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 248 APAC WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 249 APAC WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 250 APAC WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 251 APAC WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 252 APAC WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 253 APAC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2018)

TABLE 254 APAC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 255 CHINA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 256 CHINA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 257 CHINA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 258 CHINA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 259 CHINA GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 260 CHINA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 261 CHINA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 262 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 263 CHINA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 264 CHINA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 265 CHINA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 266 CHINA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 267 CHINA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 268 CHINA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 269 CHINA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 270 CHINA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 271 CHINA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 272 CHINA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 273 CHINA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 274 CHINA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 275 CHINA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 276 CHINA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 277 JAPAN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 278 JAPAN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 279 JAPAN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 280 JAPAN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 281 JAPAN GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 282 JAPAN GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 283 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 284 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 285 JAPAN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 286 JAPAN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 287 JAPAN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 288 JAPAN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 289 JAPAN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 290 JAPAN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 291 JAPAN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 292 JAPAN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 293 JAPAN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 294 JAPAN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 295 JAPAN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 296 JAPAN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 297 JAPAN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 298 JAPAN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 299 INDIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 300 INDIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 301 INDIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 302 INDIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 303 INDIA GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 304 INDIA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 305 INDIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 306 INDIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 307 INDIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 308 INDIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 309 INDIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 310 INDIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 311 INDIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 312 INDIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 313 INDIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 314 INDIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 315 INDIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 316 INDIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 317 INDIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 318 INDIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 319 INDIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 320 INDIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 321 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 322 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 323 AUSTRALIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 324 AUSTRALIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 325 AUSTRALIA GROWTH FACTORS MARKET, BY TYPE, $M (2014–2018)

TABLE 326 AUSTRALIA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)

TABLE 327 AUSTRALIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 328 AUSTRALIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 329 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 330 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 331 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 332 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 333 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 334 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 335 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 336 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 337 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 338 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 339 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 340 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 341 AUSTRALIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 342 AUSTRALIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 343 LATAM WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 344 LATAM WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 345 LATAM SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 346 LATAM SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 347 LATAM GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 348 LATAM GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 349 LATAM CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 350 LATAM CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 351 LATAM WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 352 LATAM WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 353 LATAM WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 354 LATAM WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 355 LATAM WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 356 LATAM WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 357 LATAM WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 358 LATAM WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 359 LATAM WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 360 LATAM WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 361 LATAM WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 362 LATAM WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 363 LATAM WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 364 LATAM WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 365 LATAM WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2018)

TABLE 366 LATAM WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 367 MEXICO WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 368 MEXICO WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 369 MEXICO SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 370 MEXICO SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 371 MEXICO GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 372 MEXICO GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 373 MEXICO CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 374 MEXICO CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 375 MEXICO WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 376 MEXICO WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 377 MEXICO WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 378 MEXICO WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 379 MEXICO WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 380 MEXICO WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 381 MEXICO WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 382 MEXICO WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 383 MEXICO WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 384 MEXICO WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 385 MEXICO WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 386 MEXICO WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 387 MEXICO WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 388 MEXICO WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 389 BRAZIL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 390 BRAZIL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 391 BRAZIL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 392 BRAZIL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 393 BRAZIL GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 394 BRAZIL GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 395 BRAZIL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 396 BRAZIL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 397 BRAZIL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 398 CHINA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 399 BRAZIL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 400 BRAZIL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 401 BRAZIL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 402 BRAZIL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 403 BRAZIL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2014–2018)

TABLE 404 BRAZIL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2019–2024)

TABLE 405 BRAZIL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 406 BRAZIL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 407 BRAZIL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 408 BRAZIL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 409 BRAZIL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 410 BRAZIL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 411 MEA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 412 MEA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 413 MEA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 414 MEA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 415 MEA GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 416 MEA GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 417 MEA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 418 MEA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 419 MEA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 420 MEA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 421 MEA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 422 MEA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 423 MEA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 424 MEA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 425 MEA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 426 MEA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 427 MEA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 428 MEA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 429 MEA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 430 MEA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 431 MEA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 432 MEA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 433 MEA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2018)

TABLE 434 MEA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 435 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 436 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 437 SAUDI ARABIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 438 SAUDI ARABIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 439 SAUDI ARABIA GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 440 SAUDI ARABIA GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 441 SAUDI ARABIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 442 SAUDI ARABIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 443 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 444 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 445 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 446 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 447 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 448 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 449 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2014–2018)

TABLE 450 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)

TABLE 451 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 452 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 453 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 454 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 455 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 456 SAUDI ARABIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 457 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 458 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 459 SOUTH AFRICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 460 SOUTH AFRICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 461 SOUTH AFRICA GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 462 SOUTH AFRICA GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 463 SOUTH AFRICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 464 SOUTH AFRICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 465 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 466 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 467 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 468 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 469 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 470 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 471 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2014–2018)

TABLE 472 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2019–2024)

TABLE 473 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 474 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 475 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 476 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 477 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 478 SOUTH AFRICA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 479 ISRAEL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2018)

TABLE 480 ISRAEL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 481 ISRAEL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2014–2018)

TABLE 482 ISRAEL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)

TABLE 483 ISRAEL GROWTH FACTORS MARKET, BY TYPE, $000’ (2014–2018)

TABLE 484 ISRAEL GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)

TABLE 485 ISRAEL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2014–2018)

TABLE 486 ISRAEL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)

TABLE 487 ISRAEL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2018)

TABLE 488 ISRAEL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)

TABLE 489 ISRAEL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2018)

TABLE 490 ISRAEL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)

TABLE 491 ISRAEL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2018)

TABLE 492 ISRAEL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 493 ISRAEL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2014–2018)

TABLE 494 ISRAEL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $000’ (2019–2024)

TABLE 495 ISRAEL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2014–2018)

TABLE 496 ISRAEL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)

TABLE 497 ISRAEL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2018)

TABLE 498 ISRAEL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)

TABLE 499 ISRAEL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2014–2018)

TABLE 500 ISRAEL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)

TABLE 501 LIST OF KEY PLAYERS AND THEIR OFFERINGS

TABLE 502 SMITH & NEPHEW PLC – AT A GLANCE

TABLE 503 SMITH & NEPHEW PLC – KEY FINANCIAL SUMMARY

TABLE 504 MÖLNLYCKE HEALTH CARE AB – AT A GLANCE

TABLE 505 MÖLNLYCKE HEALTH CARE AB – KEY FINANCIAL SUMMARY

TABLE 506 INTEGRA LIFESCIENCES CORPORATION – AT A GLANCE

TABLE 507 INTEGRA LIFESCIENCES CORPORATION – KEY FINANCIAL SUMMARY

TABLE 508 WRIGHT MEDICAL GROUP N.V. – AT A GLANCE

TABLE 509 MIMEDX GROUP INC. – AT A GLANCE

TABLE 510 VERICEL CORPORATION – AT A GLANCE

TABLE 511 ANIKA THERAPEUTICS INC. – AT A GLANCE

TABLE 512 OSIRIS THERAPEUTICS INC. – AT A GLANCE

TABLE 513 ORGANOGENESIS INC. – AT A GLANCE

TABLE 514 KERECIS LIMITED – AT A GLANCE

TABLE 515 SOLSYS MEDICAL – AT A GLANCE

TABLE 516 ACELL INC. – AT A GLANCE

TABLE 517 MARINE POLYMER TECHNOLOGIES INC. – AT A GLANCE

TABLE 518 SKYE BIOLOGICS INC. – AT A GLANCE

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL WOUND CARE BIOLOGICS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 SNAPSHOT OF GLOBAL WOUND CARE BIOLOGICS MARKET

FIG 15 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 16 GLOBAL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 17 GLOBAL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 18 GLOBAL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 19 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 20 WORLDWIDE MAJOR MARKETS FOR WOUND CARE BIOLOGICS

FIG 21 NORTH AMERICA WOUND CARE BIOLOGICS MARKET SNAPSHOT

FIG 22 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 23 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 24 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 25 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 26 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 27 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2024)

FIG 28 EUROPE WOUND CARE BIOLOGICS MARKET SNAPSHOT

FIG 29 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 30 EUROPE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 31 EUROPE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 32 EUROPE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 33 EUROPE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 34 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2024)

FIG 35 APAC WOUND CARE BIOLOGICS MARKET SNAPSHOT

FIG 36 APAC WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 37 APAC WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 38 APAC WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 39 APAC WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 40 APAC WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 41 APAC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2024)

FIG 42 LATAM WOUND CARE BIOLOGICS MARKET SNAPSHOT

FIG 43 LATAM WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 44 LATAM WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 45 LATAM WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 46 LATAM WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 47 LATAM WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 48 LATAM WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2024)

FIG 49 MEA WOUND CARE BIOLOGICS MARKET SNAPSHOT

FIG 50 MEA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2014–2024)

FIG 51 MEA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2014–2024)

FIG 52 MEA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2014–2024)

FIG 53 MEA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2014–2024)

FIG 54 MEA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2014–2024)

FIG 55 MEA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2014–2024)

FIG 56 SMITH & NEPHEW PLC – REVENUE SPLIT BY PRODUCT FRANCHISE AND GEOGRAPHY (2018)

FIG 57 MÖLNLYCKE HEALTH CARE AB – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2018)

FIG 58 INTEGRA LIFESCIENCES CORPORATION – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2018)

Place An Order
USD 4900 USD 5900 USD 7500
Customized Report Solution

Get a bespoke market intelligence solution

 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need Us

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws